Table 1. Descriptive data of the study sample.
| Variable | N (Total = 110) | % | Mean | Std. Dev. | Min | Q1 | Median | Q3 | Max |
|---|---|---|---|---|---|---|---|---|---|
| Migraine frequency | |||||||||
| Chronic | 58 | 53% | |||||||
| Episodic | 52 | 47% | |||||||
| Aura | |||||||||
| No | 33 | 30% | |||||||
| Visual | 70 | 64% | |||||||
| Motor | 40 | 36% | |||||||
| Sex | |||||||||
| F | 97 | 88% | |||||||
| M | 13 | 12% | |||||||
| Academic level | |||||||||
| Primary | 3 | 3% | |||||||
| Secondary | 10 | 9% | |||||||
| College | 97 | 88% | |||||||
| Employment status | |||||||||
| Student | 28 | 25% | |||||||
| Unemployed | 10 | 9% | |||||||
| Active | 69 | 63% | |||||||
| Retired | 3 | 3% | |||||||
| Comorbidities | |||||||||
| Tensional-type headache | 20 | 20% | |||||||
| Trigeminal autonomic cephalalgias | 1 | 1% | |||||||
| Depression | 5 | 5% | |||||||
| Anxiety | 5 | 5% | |||||||
| Major psychiatric disorders | 3 | 3% | |||||||
| POS | 5 | 5% | |||||||
| Musculoskeletal disorders | 6 | 5% | |||||||
| Hypo/hyperthyroidism | 7 | 6% | |||||||
| Asthma | 5 | 5% | |||||||
| Psoriasis | 3 | 3% | |||||||
| Fibromyalgia | 2 | 2% | |||||||
| Gastro-intestinal inflammatory disease | 8 | 7% | |||||||
| Cardiovascular disease | 13 | 12% | |||||||
| Hematological disease | 2 | 2% | |||||||
| Diabetes Type II | 3 | 3% | |||||||
| Neurological disease | 5 | 5% | |||||||
| Visual disorders | 3 | 3% | |||||||
| Age (y) | 36 | 12 | 18 | 26 | 32 | 45 | 64 | ||
| Height (cm) | 166 | 7 | 150 | 162 | 166 | 170 | 188 | ||
| Weight (kg) | 68 | 13 | 46 | 59 | 66 | 75 | 112 | ||
| BMI (Kg/m2) | 25 | 4 | 17 | 21 | 24 | 27 | 39 | ||
| IPAQ-SF vigorous | 872 | 1,070 | 0 | 0 | 480 | 1,440 | 6,000 | ||
| IPAQ-SF moderate | 552 | 911 | 0 | 0 | 240 | 720 | 5,760 | ||
| IPAQ-SF walking | 1,149 | 954 | 0 | 516 | 792 | 1,386 | 4,158 | ||
| IPAQ-SF total | 2,573 | 2,003 | 0 | 1,045 | 2,056 | 3,746 | 8,532 | ||
| IPAQ-SF category | |||||||||
| Sedentary | 16 | 15% | |||||||
| Moderate | 52 | 46% | |||||||
| High | 43 | 39% | |||||||
| TSK-11 total | 23 | 7.1 | 11 | 16 | 23 | 27 | 42 | ||
| PCS total | 21 | 13 | 0 | 10 | 20 | 32 | 49 | ||
| FAB-Q total | 27 | 17 | 0 | 14 | 23 | 39 | 80 | ||
| HIT-6 total | 64 | 6.5 | 48 | 60 | 64 | 69 | 78 | ||
| NDI total | 11 | 7.9 | 1 | 4 | 9 | 15 | 38 | ||
| CPSES total | 124 | 34 | 17 | 104 | 128 | 146 | 188 | ||
| SEQRE total | 346 | 176 | 0 | 210 | 350 | 480 | 700 | ||
| Walking fear | 1.9 | 1.7 | 1 | 1 | 1 | 2 | 9 | ||
| Walking difficulty | 1.9 | 1.6 | 1 | 1 | 1 | 2 | 8 | ||
| Running fear | 4.2 | 3.1 | 1 | 1 | 4 | 7 | 10 | ||
| Running difficulty | 4 | 2.7 | 1 | 2 | 3 | 6 | 10 | ||
| Jumping fear | 4.5 | 3 | 1 | 1 | 5 | 7 | 10 | ||
| Jumping difficulty | 3.7 | 2.8 | 1 | 1 | 3 | 6 | 10 | ||
| Neck rotation fear | 2.9 | 2.5 | 1 | 1 | 2 | 4 | 10 | ||
| Neck rotation difficulty | 2.4 | 2.2 | 1 | 1 | 1 | 3 | 10 | ||
| Neck flexion/extension fear | 3.2 | 2.7 | 1 | 1 | 2 | 4 | 10 | ||
| Neck flexion/extension difficulty | 2.6 | 2.4 | 1 | 1 | 1.5 | 3 | 10 | ||
| Spine flexion fear | 3.7 | 2.8 | 1 | 1 | 3 | 6 | 10 | ||
| Spine flexion difficulty | 3.1 | 2.5 | 1 | 1 | 2 | 5 | 10 | ||
| Spine extension fear | 4.5 | 3 | 1 | 1.2 | 4 | 7 | 10 | ||
| Spine extension difficulty | 4.4 | 2.8 | 1 | 2 | 4 | 7 | 10 | ||
| Squatting fear | 3 | 2.5 | 1 | 1 | 2 | 4 | 10 | ||
| Squatting difficulty | 3.5 | 2.4 | 1 | 1 | 3 | 5 | 10 | ||
| Shoulder press fear | 2.7 | 2.3 | 1 | 1 | 2 | 4 | 10 | ||
| Shoulder press difficulty | 3.2 | 2.2 | 1 | 1 | 3 | 4 | 10 |
Note:
BMI, Body mass index; CPSES, chronic pain self-efficacy scale; F, female; FAB-Q, fear-avoidance beliefs questionnaire; HIT-6, headache impact test; IPAQ-SF, international physical activity questionnaire-short form; M, male; Max, maximum value; Min, minimum value; N, number of participants; NDI, neck disability index; PCS, pain catastrophizing scale; POS, polycystic ovary syndrome; Q1, first quartile; Q3, third quartile; SEQRE, self-efficacy questionnaire to regulate exercise; Std. Dev., standard deviation; TSK-11, TAMPA scale of kinesiophobia.